Latest Research & Development
AHA Scientific Sessions Publication — November 2024
Coordination Index Guides Synchronous Non-Blood Contacting Support of the Failing Heart.
American Society for Artificial Internal Organs — Baltimore, MD — May 29 - June 1, 2024
Dr. Mark Anstadt Presented "Ventricular Function Improves Following Non-Blood Contacting Direct Mechanical Ventricular Actuation Compared to LVAD Support in the Small Chronically Failing Heart" during ASAIO conference.
Myocardial Strain Technologies also presented MyST Inc’s Novel Pedi-MyST Heart Pump at the 2024 ASAIO Annual Conference during the Pediatric Medical Device Day Course.
American Society for Artificial Internal Organs — Baltimore, MD — May 29 - June 1, 2024
Myocardial Stain Technologies presented at the ASAIO conference.
LSI Emerging Medtech Summit — Dana Point, CA — March 18-22, 2024
Deborah Conley, Myocardial Strain Technologies - Non-Blood Contacting Heart Pump | LSI USA '24
Myocardial Strain Technologies is embarking on commercializing MyST-I, a non-blood-contacting heart pump with promising results in human clinical trials and extensive animal studies.
STS 2024 — San Antonio, TX — January 27-29, 2024
Direct Mechanical Ventricular Actuation of the Acutely Failing Heart Improves Left Ventricular Recovery and Maladaptive Cell Signaling
AHA Scientific Sessions Publication — Philadelphia, PA — November, 2023
Augmentation Of Right Ventricular Strain Dynamics During Direct Mechanical Ventricular Actuation
AHA Scientific Sessions Publication — Philadelphia, PA — November, 2023